FeesSafety
Pluang+

Rakovina Therapeutics to present new ATR inhibitor data for PTEN-deficient prostate cancer at major cancer symposium

Market News
16 Nov 2026, 12:30 WIB
GlobeNewsWire
View Source
Bullish
Rakovina Therapeutics to present new ATR inhibitor data for PTEN-deficient prostate cancer at major cancer symposium

Rakovina Therapeutics announced it will present preclinical data on its kt-5000AI ATR inhibitor program targeting PTEN-deficient prostate cancer at the 38th EORTC-NCI-AACR Symposium in Barcelona. The data highlights novel ATR inhibitors designed with AI technology to exploit vulnerabilities in tumors lacking the PTEN gene, a common alteration in prostate cancer. The program focuses on brain-penetrant, ATR-selective compounds with potential for dual ATR/mTOR inhibition. This research is still in preclinical stages, with ongoing lead optimization aimed at advancing toward clinical trials.

Rakovina Therapeutics' ATR inhibitor program for PTEN-deficient prostate cancer is the subject, with Pluang's Health sector data providing market context. As of Nov 16, 2026 17:41 WIB, 60 of 150 priced Health-sector US stocks rose while 50 fell. Notable movers include TNGX at USD 24.99 with a -2.00% change, NVO at USD 42.46 with a +1.99% change, and RVMD at USD 169.02 with a -1.90% change.

More News

Credit Agricole Toulouse 31 reports weekly transactions on cooperative investment certificates.

Credit Agricole Toulouse 31 reports weekly transactions on cooperative investment certificates.

Credit Agricole Toulouse 31 disclosed its weekly transactions on cooperative investment certificates (CCI) for the period from November 9 to November 13, 2026. The report details daily volumes and average acquisition prices, showing active buybacks o...

Market News
Neutral
47 minutes ago
Euronet and Getnet integrate VAT refund into payment terminals for smoother Tax Free shopping in Spain.

Euronet and Getnet integrate VAT refund into payment terminals for smoother Tax Free shopping in Spain.

Euronet and Getnet, Santander Group's payment platform, have partnered to integrate VAT refund services directly into payment terminals in Spain. This collaboration allows merchants to process Tax Free transactions seamlessly at the point of sale, si...

Market News
Bullish
47 minutes ago
Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank buys back 25,000 shares in week 46, continuing its DKK 4.5 billion buy-back program.

Danske Bank executed transactions to repurchase 25,000 shares during week 46 as part of its ongoing share buy-back program announced in February 2026. The program targets a total buy-back of up to DKK 4.5 billion or 45 million shares by January 2027....

Company Fundamentals
Neutral
1 hour ago
French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

French firms boost AI-driven cybersecurity, focusing on productivity and operational results over processes.

A new study by Securonix shows French organizations are increasingly adopting AI-driven cybersecurity operations, prioritizing productivity and measurable outcomes rather than just processes. French firms lead in allowing AI to automatically trigger ...

Market News
Neutral
2 hours ago
Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics launches new €50M share buyback after completing initial program

Lakefront Biotherapeutics has started a new €50 million share buyback program following the completion of its initial €50 million program, in which it repurchased about 1.99 million shares. The new program, running until March 31, 2027, aims to enhan...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App